Academia.eduAcademia.edu

FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE

2014, Revista do Instituto de Medicina Tropical de São Paulo

Abstract
sparkles

AI

This report highlights the ototoxicity of meglumine antimoniate, a drug widely used for treating leishmaniasis. The findings indicate significant auditory impairment associated with its usage, necessitating further investigation into its safety profile. Recommendations for monitoring auditory function in patients receiving the treatment are discussed.